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Increasing ED Use of Jet
Injection of Lidocaine for
IV-Related Pain Management
Shobhit Jain, MD,a,b Mary A. Hegenbarth, MD,a,b Sharon G. Humiston, MD,a,b
Erin Gunter, RN, BSN,a Lynn Anson, RN-BC,c Joan E. Giovanni, MDa,b

BACKGROUND AND OBJECTIVE: Venipuncture is a leading cause of procedural pain
for children. Jet injection of lidocaine (JIL; J-Tip) has been demonstrated to
be effective in controlling intravenous (IV) placement–related pain and, due
to its rapid onset, is particularly suited to emergency department (ED) use.
Our objective was to increase JIL use with IV placements in our ED from
11% at baseline to 50% within 12 months.
METHODS: We initiated the project at our urban, tertiary pediatric ED in July

2014. We surveyed medical and nursing teams to identify barriers to JIL use.
We initiated changes at monthly intervals: (1) order set changes, (2) online
education, (3) hands-on workshops, (4) improved accessibility, (5) standing
order policy revision, and (6) reminders. We collected biweekly data on IV
placements for all ED patients, except level 1 (critical) triage patients. We
used standard quality improvement methodology and statistical process
control for statistical analysis.

RESULTS: JIL use with IV placement increased to 54% over 7 months and has

remained >50% for >12 months. For all eligible IV placements (n = 12 791),
76.4% of those where JIL was used were successful on the first attempt
compared with 75.8% without JIL (χ21degrees of freedom = 0.33, P = .56), with no
significant difference in the success at IV placement.
CONCLUSIONS: We sustainably increased JIL use with IV placement. The use

of JIL was not associated with a difference in first-attempt IV placement
success rates. We are expanding the project to other parts of the institution.

Elimination or relief of pain,
whenever possible, is an important
responsibility of all health care
providers caring for children. Many
pediatric patients in the emergency
department (ED) either present
with a painful condition or undergo
painful procedures as a part of
their evaluation and management.
Resolution of both pain and caregiver
perception of pain have been
identified as important indicators
of patient and parent satisfaction
in the ED.1 Improvement in pain
control has been associated with

significantly improved clinical and
practice outcomes.2 In contrast, poor
pain control has been demonstrated to
have a variety of short- and long-term
complications, including hyperalgesia
and needle phobia.3,4 In addition to
patient-related outcomes, poor pain
control in the pediatric patient also
has been shown to affect the vital
signs of caregivers.5
Anand et al6 first demonstrated
the importance of adequate pain
management in infants. Pain
management has since been
increasingly recognized as an important
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part of high-quality patient care.
In 2001, the American Academy of
Pediatrics recognized acute pain to be
a serious issue, with the potential to
lead to physiologic and psychological
adverse effects, and reaffirmed this
statement in 2015.7– 9 Additionally, the
Joint Commission on Accreditation of
Healthcare Organizations introduced
standards requiring pain assessment
and management.10 However, studies
continue to demonstrate insufficient
pain management, particularly for
children in EDs.11 Commonly reported
barriers to optimal pain management
include poor assessment of pain,
inadequate education about pain and
pain control measures, and perceived
time constraints to administer the
analgesic measure.7,8,
 12


Venipuncture and intravenous
(IV) cannulation are common
procedures performed in the
emergency care of pediatric patients
and are increasingly recognized
as the leading cause of procedurerelated pain in pediatric hospital
and ED settings.13 Fortunately,
there are several pharmacologic
and nonpharmacologic measures
available to provide analgesia for
needlestick procedures. Recently,
several topical anesthetic options
have been studied for use with
venipunctures in the ED (see
Table 1). Pershad et al14 analyzed
commonly available options and
concluded that jet injection of
lidocaine (JIL; J-Tip) provided rapid
onset of maximal analgesia with the
lowest cost-effectiveness ratio.14
JIL delivers 1% buffered lidocaine
into the subcutaneous tissue using
pressurized carbon dioxide and has
been demonstrated to be superior
to topical anesthetic creams, such as
eutectic mixture of local anesthetics
and liposomal lidocaine, for ED
 The rapid onset of effect is
use.15,16
particularly helpful in the ED setting,
where providers and patients are
frequently unwilling to wait for
longer-acting agents to work.
e2

TABLE 1 Common Topical Anesthetics for Venipunctures
Anesthetic

Brand Names

Vapocoolant spray
Eutectic mixture of local anesthetics: lidocaine and prilocaine
4% liposomal lidocaine cream
JIL device
Lidocaine and tetracaine topical patch

At baseline, measured over 6 months,
JIL was used with only 11% of IV
placements at our urban, tertiary
care children’s hospital ED. We used
a multimodal and multidisciplinary
quality improvement (QI) initiative
to address the suboptimal use of this
agent. Our objective was to increase
use of JIL with IV placements in
noncritical ED patients from 11%
to 50% within 12 months (outcome
measure). Our process measure was
to compare, over time, the number of
orders initiated by the medical team
with the number of nurse-initiated
orders. For our balancing measure, we
assessed whether the use of JIL was
associated with a reduced success rate
in first-attempt IV placement.

Methods
Ethical Aspects
The project was reviewed by our
institutional review board, which
determined that it met criteria to be
classified as a QI project.

Setting and Population

Our institution’s main campus is
a 317-bed pediatric tertiary care
referral center serving patients from
western Missouri, all of Kansas, and
eastern Colorado. Our QI project was
initiated at this urban ED, which is a
39-bed facility with an annual census
of ∼70 000 patients. For staffing
purposes, this ED is divided into 5
spatially distinct zones with nursing
staff assigned to a specific zone. The
patients are triaged according to the
Emergency Severity Index17 (ESI)
from levels 1 (most urgent) to 5 (least
urgent). In 2013, among noncritical

Pain-Ease
EMLA
AneCream, L.M.X.4
J-Tip, Zingo
Synera

patients (ESI categories 2–5), ∼25
IV placements were ordered per day
(∼750 per month). All ED patients
who had orders for peripheral IV
placement were included unless
they (1) had a documented history
of allergy to lidocaine, or (2) were
triaged as “critical” (ESI triage level 1).

Improvement Team

The team was multidisciplinary
and included a pediatric emergency
medicine (PEM) fellow (Dr
Jain), 3 PEM faculty members
(Drs Hegenbarth, Giovanni, and
Humiston), an ED nurse (Ms Gunter),
and a pain management nurse (Ms
Anson). A QI specialist (Ms Hunter),
child life specialist (Ms DePhillips),
nurse educator (Mr Winfrey), and
statistician (Ms Sherman) provided
additional assistance. We initiated
the project in July 2014 and used the
Institute for Healthcare Improvement
model for improvement.18

Planning the Interventions

From the hospital’s electronic
medical record system, we collected
baseline data for the 6 months before
launch (January to June 2014). Based
on the consensus of the improvement
team, we created process maps to
illustrate the current process from
considering to administering JIL with
IV placement, as illustrated in Fig 1.
The improvement team identified key
drivers and used process maps to run
failure mode and effects analysis.19
Before planning the intervention, we
conducted an electronic, anonymous
survey of ED physicians and nurses to
assess their knowledge, attitudes, and
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and tests of change to modify and
spread the interventions within the
ED. The project run chart in Fig 3 is
annotated with the start dates of each
intervention. A detailed description of
the 6 interventions in order of launch
date follows.

(1) Order Set Changes: August 2014

Our ED uses order sets to help
clinicians easily order tests,
procedures, etc for common chief
complaints and diagnoses. In
collaboration with the medical
informatics team managing the
hospital’s electronic medical record
system (Cerner Corporation, Kansas
City, MO), the option to order JIL was
included in all order sets that had an
IV placement option so that ordering
JIL with each IV placement would
be easier for the provider and, thus,
occur more reliably.

FIGURE 1

Process map and opportunities for intervention.

(2) Online Education: September 2014

FIGURE 2

Pareto chart: combined nurse and physician survey results to the question, “What is the one
intervention that would lead you to use JIL (J-Tip) with IV placements?”

practices related to IV placement pain
management in general and JIL use in
particular. We analyzed data obtained
from 85 nurses (80% response rate)
and 105 medical providers (72%
response rate; respondents included
43 residents, 7 fellows, 31 PEM faculty,
and 24 nurse practitioners). Among
the nurses, the leading barriers were
the physician ordering process, noise
with JIL administration, and concern
for “blown veins” or IV placement
failure. Among providers, the leading
barriers were lack of knowledge,
the complicated ordering process,
and nursing staff’s reluctance to use
JIL. We also asked, “What is the one
intervention that would lead you

to use JIL with IV placements?” The
cumulative responses to the question
are illustrated in a Pareto chart (Fig 2).

Interventions

We designed the interventions with
the aim of increasing JIL use for IV
placements in the ED. We planned our
interventions based on expert opinion,
improvement team input, including the
process map (Fig 1), and ED personnel
responses to the survey, including
those depicted in the Pareto chart
(Fig 2). We identified 6 opportunities
for improvement and translated
them into interventions, conducting
multiple plan–do–study–act cycles

The improvement team created an
online resource document about
JIL that was posted on the hospital
internal Web page and also shared
in emails with the ED staff. This
document included facts about JIL
and IV-related pain, Web links to
individually selected videos with
instructions on using JIL, and answers
to common concerns identified on the
preintervention survey.

(3) Workshops: October 2014

The improvement team recruited 10
experienced ED nurses and trained
them to be JIL super users. With their
assistance, we scheduled workshops
for nurses and physicians to provide
hands-on experience. Workshops
were brief (5–10 minutes) and held
at convenient locations and times (eg,
in the break room during lunch or
occasionally at nurses’ workstations
between patient care tasks) to
minimize impediments to the ED
workflow.

(4) Accessibility: November 2014

JIL devices need refrigeration for
storage. At our ED, JIL was initially
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After the final intervention, we
administered a follow-up survey to
ED physicians and nurses to obtain
feedback on the interventions as well
as on self-reported knowledge and
satisfaction.

Data Collection

FIGURE 3

Outcome measure: run chart annotated with interventions.

stocked in only 1 of 5 zones, making
access inconvenient for much of
the ED and causing a barrier to
wider use. Wall refrigerators were
installed with assistance from the ED
pharmacy and administration so JIL
could be stocked in all ED zones.

(5) Policy Change: December 2014

At baseline, the hospital had a
standing order policy in place that
allowed nurses to place specific
orders (eg, oral antipyretics, topical
anesthetics for needlesticks) to
improve efficiency. However, these
standing order policies applied only
until a medical provider evaluated
the patient. This was a major barrier
to JIL use because the need for most
IV placements is determined after the
TABLE 2 Measures and Data Sources
Measure
Outcome measure
Numerator
Numerator (Corroborative)
Denominator
Process Measure

Balance measure
Numerator

Denominator

e4

initial medical evaluation. Providers
often forgot to place the order, and
nurses found it burdensome to find
and ask providers to request JIL
orders. The standing order policy was
modified to allow orders for topical
anesthetics by the nurse even after the
medical evaluation had taken place.

(6) Reminders: January 2015

Our last intervention was to place a
small placard on all ED workstations
to remind staff to consider
ordering/using JIL with every IV.
To emphasize the changes and
provide positive feedback, we also
sent reminder emails that included
recognition for the nurse with the
highest number of IVs placed with
JIL.

 able 2 highlights the data sources.
T
For the outcome and balancing
measures, the improvement team
obtained pooled and deidentified data
from electronic order entries through
the hospital’s division of medical
informatics and corroborative data
on JIL ordering from the pharmacy
department. Data collected included
age, number of IV placement attempts,
and JIL use on the same visit as IV
placement. We selected biweekly
data collection and review to ensure
sampling strategy adequacy for
analysis of the effects of the changes.
Because we initiated the changes
at monthly intervals, the biweekly
measurement cycles also enabled us
to analyze, modify, and spread the
intervention before the initiation of
the next step.

Planning the Study of the
Intervention: Measures

•• For our outcome measure, we

assessed the proportion of ED
patients in ESI triage levels 2
through 5 requiring IV placement
who had JIL associated with IV
placement.

Data Collected Biweekly
JIL use rate
Total No. of JIL orders placed
Total No. of JIL dispensed
Total No. of IV placement orders
Comparison of orders from medical providers and nurses
JIL orders by medical provider (MD/DO/NP)
JIL orders by nurse (RN)
Comparison of success of first-attempt IV placement when a JIL was used versus not used
No. of IVs placed at first attempt
   When a JIL was used
   When a JIL was not used
Total No. of IVs placed
   When a JIL was used
   When a JIL was not used
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Pharmacy
Medical informatics
Medical informatics

Medical informatics
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Jain et al

Process Measure
We observed an increase in nurseinitiated JIL orders from 15% during
the baseline period to 60% of all JIL
orders after the interventions, as
illustrated in Fig 4. The number of
JIL devices ordered by providers also
increased during this period.

Balance Measure

FIGURE 4

Process measure: trend of JIL orders by personnel, medical versus nursing.

•• For our process measure, we

compared the number of JIL orders
placed by medical staff (physicians
and nurse practitioners) versus
nursing staff.

•• Our balancing measure assessed

whether the use of JIL was
associated with a reduction in the
success rate of placing IVs at first
attempt. The perception of reduced
IV placement success rate with JIL
was one of the barriers to JIL use.

Data Analysis

We evaluated data for 12
measurement cycles (6 months)
before the interventions, 14 cycles
(7 months) during the interventions,
and 24 cycles (12 months) after
the final intervention. We used the
following outcome-directed tools to
study our measures: (1) run charts for

quantitative analysis of biweekly data
for the outcome measure; (2) time
series of the proportion of JIL orders
based on the originating personnel;
and (3) the χ2 test to compare the
success rates for all IV placements
with and without the use of JIL.

Results
Outcome Measure
Before the initiative, only 11% of IV
placements were associated with
JIL use. Within 14 measurement
cycles (7 months) of the first
intervention, 54% of IV placements
were associated with JIL use. During
the monitoring period after the final
intervention (24 cycles, 12 months),
the proportion of IV placements with
JIL remained ≥50%. The results for
the outcome measure are depicted in
a run chart in Fig 3.

We reviewed data on all eligible IVs
during the baseline, intervention, and
follow-up periods, categorized by
patient age groups. For the total IV
placements during the observation
period (n = 12 791), there was no
statistically significant difference in the
proportion of successful placements
on the first attempt between those
associated and not associated
with JIL orders at the same visit
(76.4% vs 75.8%, respectively,
χ21degrees of freedom = 0.33, P = .56).
Similarly, there was no statistically
significant difference when the data
were stratified by age, as shown in
Table 3.

Discussion

In a busy pediatric ED, we used QI
methodology to sustainably increase
JIL use with IV placements from 11% to
>50%. This improvement was effected
over 14 measurement cycles (7
months) with multiple plan–do–study–
act cycles. We modified and spread
the intervention within the pediatric
ED with tests of change with each
measurement cycle. The improved
usage rate of ≥50% remained
sustained for 24 measurement cycles
(12 months) after the last intervention.
Implementation of a standing order

TABLE 3 Balancing Measure: Comparison of IV Placement First-Attempt Success Rates With And Without JIL Order, by Patient Age
Age, y
<2
2–4.9
5–7.9
8–11.9
12–18
Total

IV Without JIL

IV With JIL

P

On First Attempt

Total

Success Rate, %

On First Attempt

Total

Success Rate, %

1925
1258
967
1116
2154
7420

2870
1632
1183
1402
2706
9793

67.1
77.1
81.7
79.6
79.6
75.8

365
392
363
473
696
2289

527
498
460
604
909
2998

69.3
78.7
78.9
78.3
76.6
76.4
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policy that allowed JIL ordering by
nurses resulted in an increase in
nurse-initiated orders to 60% of all
JIL orders within 6 cycles (3 months).
There were no significant differences
in the first-attempt success rates for IV
placements with or without the use of
JIL overall or for any age group.

We used robust measurements,
included assessment of corroborative
data for our outcome of primary
interest, and determined the
sustainability of the effort for many
months after the last change. Our
results were strikingly positive and
were followed by the adoption of
similar methods by other areas of
the organization. This has also been
regarded as a sentinel project for a
culture change to improve procedural
pain management at the ED and the
institution. The improvement team has
assisted with education in other areas
and sharing our methods, enabling
a successful increase in JIL use at 2
pediatric urgent care centers. At the
ED, we are working to better address
pain related to other procedures and
painful states, including sickle cell
disease and long-bone fractures.
The interventions and the order of
their application allowed us to affect
our key drivers and reach our goal of
increased JIL use. We arranged our
interventions based on the results
of the needs assessment survey,
failure mode and effects analysis,
and system factors, including the
convenience of implementation.

•• We started with electronic medical
record order set changes to
simplify the JIL ordering process
while planning the educational
intervention.

•• Educational interventions

included online education and
hands-on workshops. We believe
the educational component was
key to the success of the project
because it laid out the rationale and
methodology for increasing JIL use.
We know that the education was
effective at increasing knowledge

e6

based on the comparison of the preand postintervention survey data.

•• With assistance from ED

management and the pharmacy
department, we were able to
improve accessibility by stocking
JIL devices in all the ED zones.

•• Implementation and promotion

of standing orders for topical
anesthetic agents appeared to
be a substantial driver of the
improvement in JIL usage rates,
as reflected by a significant and
sustained increase in the proportion
of JIL devices ordered by nurses.

•• We posted reminder placards

on computers and, for 8 months,
sent reminder emails, with nurse
recognition for the highest number
of IVs with JIL. Because much work
had preceded this step, it is difficult
to assess if this change had an
additional effect.

Our study should be viewed in the
context of identified limitations. First,
we did not measure the reduction in
pain from JIL usage with the placement
of IVs. However, increased use of
JIL seems a good proxy for reduced
pain, because numerous previous
studies have demonstrated significant
improvement in pain level across all
age groups with preprocedure use of
JIL, as well as JIL’s superiority over
other commonly available options.15,
16,
 20
 We used a QI methodology, and
did not aim to study the comparative
efficacy of various topical analgesic
options. Second, we did not investigate
the cost implications of wider use of
JIL, as Pershad et al14 have previously
demonstrated the superior costeffectiveness of JIL compared with
other commonly used options.
Last, there could be data reporting
limitations. We analyzed data on the
number of JIL devices ordered on
the same ED visit as an IV placement
order. We used the net number of JIL
devices dispensed from the pharmacy
(total dispensed minus returned) as
a corroborative measure. However,
we did not have a reliable measure of

actual administration. We also did not
obtain any variable other than age and
ESI triage score that may have affected
JIL use.

Conclusions

The deleterious effects of pain in
the acute care setting are being
increasingly acknowledged, and pain
management needs to be urgently
addressed. Our project significantly
increased JIL use for IV placement–
related pain, and this increase has
been sustained at our busy tertiary
care pediatric ED. There was no
change in the success of first-attempt
IV placement using JIL. The results of
this project are likely generalizable
to other institutions and clinical
settings. Locally, we have partnered
with champions at 2 urgent care
centers and successfully improved
JIL use in these settings. Several
areas at Children's Mercy Hospital,
including the ambulatory clinics and
laboratories, are acknowledging and
addressing venipuncture-related pain
management in a similar fashion.
Institutions wishing to initiate
similar changes will likely need to
individualize their interventions
depending on local factors, such as
specific identified barriers to JIL use.
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